Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Methods: Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999–2010) received PI-Abx for 5 days, Group B (2010–2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012–2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg). Results: Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001). Conclusion: The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.
Abstract
Purpose: There is no consensus regarding adjuvant therapies following Kasai portoenterostomy (KP) for biliary atresia (BA). This study aimed to analyze the effect of extended perioperative intravenous antibiotics (PI-Abx) and adjuvant corticosteroid on cholangitis and jaundice clearance rates in the 3 years post-KP in children with BA. Methods: Data of patients who underwent KP between 1999-2018 at a single center were retrospectively analyzed. Group A (1999–2010) received PI-Abx for 5 days, Group B (2010–2012) received PI-Abx for 5 days plus low-dose prednisolone (2 mg/kg), and Group C (2012–2017) received PI-Abx for 14 days plus high-dose prednisolone (5 mg/kg). Results: Fifty-four patients were included with groups A, B, and C comprising 25, 9, and 20 patients, respectively. The number of episodes of cholangitis was 1.0, 1.6, and 1.3 per patient (p=NS) within the first year and 1.8, 2.3, and 1.7 (p=NS) over 3 years in Groups A, B, and C, respectively. The jaundice clearance rate at 6 months was 52%, 78%, and 50% (p=NS), and the 3-year native liver survival (NLS) rate was 76%, 100%, and 80% (p=NS) in Groups A, B, and C, respectively. A near-significant association was observed between the incidence of cholangitis within the first year and decompensated liver cirrhosis/death at 3 years post KP (p=0.09). Persistence of jaundice at 6 months was significantly associated with decompensated cirrhosis/death at 3 years (p<0.001). Conclusion: The extended duration of PI-Abx and adjuvant corticosteroids was not associated with improved rates of cholangitis, jaundice clearance, or NLS in patients with BA.
참고문헌 (39)
- Altman RP, "A multivariable risk factor analysis of the portoenterostomy(Kasai)procedure for biliary atresia : twenty-five years of experience from two centers", Ann Surg, 226, pp.348~353 (1997)
- Davenport M, "Biliary atresia : the King's College Hospital experience(1974-1995)", J Pediatr Surg, 32, pp.479~485 (1997)
- Ryckman FC, "Biliary atresia--surgical management and treatment options as they relate to outcome", Liver Transpl Surg, 4(5 Suppl 1), pp.S24~S33 (1998)
- Koga H, "Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients : results from a single institution", J Pediatr Surg, 48, pp.2368~2372 (2013)
- Decharun K, "Prophylactic antibiotics for prevention of cholangitis in patients with biliary atresia status post-Kasai portoenterostomy : a systematic review", Clin Pediatr(Phila), 55, pp.66~72 (2016)
- Meyers RL, "High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia", J Pediatr Surg, 38, pp.406~411 (2003)
- Stringer MD, "Kasai portoenterostomy : 12-year experience with a novel adjuvant therapy regimen", J Pediatr Surg, 42, pp.1324~1328 (2007)
- Petersen C, "Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia", Am J Gastroenterol, 103, pp.712~719 (2008)
- Suzuki T, "Evaluating patients' outcome post-Kasai operation : a 19-year experience with modification of the hepatic portoenterostomy and applying a novel steroid therapy regimen", Pediatr Surg Int, 26, pp.825~830 (2010)
- Tyraskis A, "Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy", Cochrane Database Syst Rev, 5, pp.CD008735~ (2018)
- Davenport M, "Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia", Hepatology, 46, pp.1821~1827 (2007)
- Kiriyama S, "Tokyo Guidelines 2018 : diagnostic criteria and severity grading of acute cholangitis(with videos)", J Hepatobiliary Pancreat Sci, 25, pp.17~30 (2018)
- Forum on Emerging Infections, Institute of Medicine, "2nd Workshop of the Forum on Emerging Infections; 1997 Jul 30-31" (1998), National Academy Press
- McDiarmid SV, "Selection of pediatric candidates under the PELD system", Liver Transpl, 10(10 Suppl 2), pp.S23~S30 (2004)
- European Association for the Study of the Liver, "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69, pp.406~460 (2018)
- Luo Y, "Current concept about postoperative cholangitis in biliary atresia", World J Pediatr, 4, pp.14~19 (2008)
- Chen SY, "Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy", BMC Pediatr, 18, pp.119~ (2018)
- Liu J, "Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients : a retrospective clinical study", J Pediatr Surg, 54, pp.2559~2564 (2019)
- Hung PY, "Long-term prognosis of patients with biliary atresia : a 25 year summary", J Pediatr Gastroenterol Nutr, 42, pp.190~195 (2006)
- Chung PH, "Predictors for failure after Kasai operation", J Pediatr Surg, 50, pp.293~296 (2015)
- Lünzmann K, "The influence of cholangitis on the prognosis of extrahepatic biliary atresia", Eur J Pediatr Surg, 9, pp.19~23 (1999)
- Lee JY, "Cholangitis in children with biliary atresia : health-care resource utilisation", J Paediatr Child Health, 50, pp.196~201 (2014)
- Wang Z, "Five-year native liver survival analysis in biliary atresia from a single large Chinese center : the death", liver transplantation hazard change and the importance of rapid early clearance of jaundice, 2019, pp.54, 1680~1685
- Tamgal J, "Clearance of jaundice after the modified Kasai's operation predicts survival outcomes in patients with biliary atresia", Turk J Pediatr, 61, pp.7~12 (2019)
- Pakarinen MP, "Outcomes of biliary atresia in the Nordic countries-a multicenter study of 158 patients during 2005-2016", J Pediatr Surg, 53, pp.1509~1515 (2018)
- Davenport M, "Biliary atresia in England and Wales : results of centralization and new benchmark", J Pediatr Surg, 46, pp.1689~1694 (2011)
- Ernest van Heurn LW, "Cholangitis after hepatic portoenterostomy for biliary atresia : a multivariate analysis of risk factors", J Pediatr, 142, pp.566~571 (2003)
- Wu ET, "Bacterial cholangitis in patients with biliary atresia : impact on short-term outcome", Pediatr Surg Int, 17, pp.390~395 (2001)
- Baek SH, "The epidemiology and etiology of cholangitis after Kasai portoenterostomy in patients with biliary atresia", J Pediatr Gastroenterol Nutr, 70, pp.171~177 (2020)
- Bezerra JA, "Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia : the START randomized clinical trial", JAMA, 311, pp.1750~1759 (2014)
- Cheng K, "Cholangitis in patients with biliary atresia receiving hepatoportoenterostomy : a national database study", J Pediatr Gastroenterol Nutr, 71, pp.452~458 (2020)
- Chen Y, "Postoperative steroid therapy for biliary atresia : systematic review and meta-analysis", J Pediatr Surg, 50, pp.1590~1594 (2015)
- Dillon PW, "Immunosuppression as adjuvant therapy for biliary atresia", J Pediatr Surg, 36, pp.80~85 (2001)
- Muraji T, "The improved outlook for biliary atresia with corticosteroid therapy", J Pediatr Surg, 32, pp.1103~1106 (1997)
- Alonso EM, "Impact of steroid therapy on early growth in infants with biliary atresia : the multicenter steroids in biliary atresia randomized trial", J Pediatr, 202, pp.179~185 (2018)
- McKiernan PJ, "The frequency and outcome of biliary atresia in the UK and Ireland", Lancet, 355, pp.25~29 (2000)
- Pietrobattista A, "Does the treatment after Kasai procedure influence biliary atresia outcome and native liver survival?", J Pediatr Gastroenterol Nutr, 71, pp.446~451 (2020)
- Wong ZH, "What happens after Kasai for biliary atresia? A European multicenter survey", Eur J Pediatr Surg, 29, pp.1~6 (2019)
- Mack CL, "A phase I", IIa trial of intravenous immunoglobulin following portoenterostomy in biliary atresia, 2019, pp.68, 495~501
